In-vitro Fertilization (IVF) Market Size by Research Nester Reveals the Market to Grow with a CAGR of 5.9% During 2025-2037 and Attain USD 42.9 Billion by 2037

Research Nester’s recent market research analysis on “In-vitro Fertilization (IVF) Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitor’s analysis and a detailed overview of the global in-vitro fertilization (IVF) market in terms of market segmentation by product, type of cycle, procedure, end use, and by region.
Expansion of Insurance Coverage for Fertility Treatments in addition to Corporate Help for Fertility Treatments
In many regions, governments and private insurers are expanding coverage for IVF and other fertility treatments. For instance, in May 2023, Pacific Blue Cross announced the launch of an enhanced Personal Health Insurance Health and Dental plan. This insurance also includes family planning benefits, incorporating fertility drugs, fertility treatments, and adoption. As insurance providers increasingly recognize infertility as a medical condition, more comprehensive policies are emerging, reducing out-of-pocket costs for patients. This makes IVF treatments more accessible, especially in countries where costs are prohibitive, driving market growth.
Request Report Sample@
https://www.researchnester.com/sample-request-6483
Furthermore, in response to the declining birth rates, and opting to delay pregnancies for career growth, private insurers and companies are including policies to promote family planning and offer financial support for fertility treatments. In June 2023, Quantum Health announced its partnership with Progyny, Inc. to launch new family-building benefits. This was aimed at helping employers provide comprehensive and inclusive experiences for all employees who need support to build their families. By providing coverage for fertility treatments, and family planning including IVT, and ART, companies demonstrate a commitment to employee well-being and work-life balance. This trend is projected to widen and play a significant role in the market’s growth.
Some of the major growth factors and challenges that are associated with the growth of the global in-vitro fertilization (IVF) market are:
Growth Drivers:
• Family Planning and Fertility Support
• Rising LGBTQ+ family-building options
Challenges:
The issue of accessibility for low-income individuals and marginalized communities poses a threat to the IVF market growth. Despite the advancements, the high cost of IVF remains a significant barrier for many potential patients. In regions where insurance coverage is limited or nonexistent, people with low income often face financial constraints, preventing them from seeking necessary treatments. This disparity in access not only affects the overall market but also highlights the need for targeted efforts to make treatments equitable and accessible to all.
By procedure, the global in-vitro fertilization (IVF) market is segmented into conventional IVF, IVF with intracytoplasmic sperm injections, minimal IVF, IVF with donor eggs, and other procedures. The conventional IVF segment is projected to expand at a CAGR of 5.6%, over the forecast period. Due to its established efficacy, and widespread use as the standard treatment for infertility, the conventional IVF segment is highly in demand. As the most well-researched and commonly practiced method, conventional IVF offers high success rates, particularly with technological advancements including embryo screening and culture systems. Its long track record of clinical success and familiarity among healthcare providers and patients has positioned it as the leading procedure.
By region, the Europe in-vitro fertilization (IVF) market is anticipated to generate considerable revenue by the end of 2037. Countries like the UK, Spain, and France are prominent players in the region, offering well-established fertility clinics, cutting-edge technologies, and favorable regulatory frameworks. According to the Federal Statistical Office, nearly 2,500 children in Switzerland were born as a result of assisted reproductive technology using in-vitro fertilization (IVF), in 2021. This is recorded to be 13% more than the success rate of the 2020 evaluation. The development of Physiological Intra-cytoplasmic Sperm Injection, in addition to other growth initiatives such as product launches & M&A activities adopted by prominent companies, is also generating growth for the IVF industry in Europe.
This report also provides the existing competitive scenario of some of the key players of the market, including Esco Medical, FUJIFILM Irvine Scientific, Inc., GE HealthCare Technologies, Inc., Genea BIOMEDX, Gynemed GmBH & Co. KG, Hamilton Thorne Ltd., IVFtech ApS, Merck KGaA, and others.
Access our detailed report at:
https://www.researchnester.com/reports/in-vitro-fertilization-market/6483
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919